JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chuang, P. I.
Right arrow Articles by Harlan, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chuang, P. I.
Right arrow Articles by Harlan, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 40, Issue of October 3, 1997 pp. 24813-24818
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Cytoplasmic Domain of E-selectin Contains a Non-tyrosine Endocytosis Signal*

(Received for publication, April 3, 1997)

Peter I. Chuang Dagger §, Brian A. Young Dagger , Ravi R. Thiagarajan , Carol Cornejo par , Robert K. Winn par and John M. Harlan Dagger

From the Departments of Dagger  Medicine,  Pediatrics, and par  Surgery, University of Washington, Seattle, Washington 98195

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENT
REFERENCES


ABSTRACT

E-selectin is an activation-dependent, endothelial cell-restricted adhesion molecule that is internalized and degraded rapidly once expressed on the cell surface. Tyrosine-containing structural motifs play an important role in the internalization of a number of integral proteins, and the membrane-proximal E-selectin cytoplasmic tyrosine residue (Tyr582) conforms to the endocytosis motif proposed previously. To determine the endocytosis motif in E-selectin, we selectively introduced truncation, substitution, and deletion mutations to the cytoplasmic tail of E-selectin. We analyzed the internalization kinetics of surface-expressed wild-type and mutant E-selectin constructs in transiently transfected Chinese hamster ovary cells using 125I-labeled E-selectin monoclonal antibody (125I-P6E2) in an acid elution assay. Interestingly, truncation immediately membrane proximal to Tyr582 (Delta DGS construct) did not alter internalization kinetics significantly (Delta DGS versus wild-type, mean surface half-life = 42 versus 45 min, respectively). Thus, it appears that the tyrosine residues are not required for internalization of E-selectin. Additional analyses indicated that Ser581 was necessary but alone was insufficient for surface E-selectin endocytosis. Thus, we conclude that there exists a novel non-tyrosine-containing endocytosis signal in the cytoplasmic tail which involves Ser581 and residues membrane-proximal to it.


INTRODUCTION

E-selectin (CD62E, ELAM-1) is a type I integral membrane protein restricted to activated endothelial cells with a defined time course of surface expression. It plays an important role in mediating leukocyte rolling (1-4), the first step of a cascade of leukocyte-endothelial cell adhesive interactions which leads to the recruitment of neutrophils, eosinophils, basophils, monocytes, and subsets of memory T lymphocytes to sites of tissue inflammation. After stimulation with tumor necrosis factor-alpha , interleukin-1, or lipopolysaccharide, E-selectin expression in vitro typically peaks at 4-6 h and returns to base line by 24 h (5). Under certain conditions, the expression of E-selectin is prolonged (6-8). The specific mechanisms involved in regulating E-selectin surface expression have not been elucidated fully.

Human vascular cell adhesion molecule-1 (VCAM-1)1, another type I integral membrane protein expressed on activated endothelium, is shed from the cell surface (9, 10) and does not undergo rapid internalization (11). This shedding process probably occurs as a result of metalloprotease cleavage of surface VCAM-1 at the juxtamembranous region of the extracellular domain (12). In contrast, most of the surface-expressed E-selectin undergoes efficient endocytosis and is degraded rapidly in the lysosomal compartment (11, 13-15). It is shed only slowly and in minute quantities in vitro (9, 10, 16). E-selectin internalization can be partially inhibited by the nonspecific protein kinase inhibitor staurosporine but not by inhibitors of protein kinase C, cAMP-dependent protein kinase A, or protein tyrosine kinase (11). The signal motif, presumably located within the cytoplasmic domain, mediating E-selectin endocytosis has not been determined.

Tyrosine-containing cytoplasmic motifs have been reported to mediate rapid endocytosis of a number of integral proteins. The NPXY motif in the low density lipoprotein receptor is a well defined example (17). A mutation of that tyrosine residue results in significant impairment of cellular low density lipoprotein cholesterol uptake and the phenotype of familial hypercholesterolemia in patients (18). These tyrosine-containing motifs have been postulated to assume a tight reverse turn structural conformation (19-22) that is recognized by cytoplasmic adaptor complexes that in turn mediate clathrin-coated pit localization and subsequent efficient endocytosis (23, 24). Although one study questioned the requirement for the proposed reverse turn structural conformation of the tyrosine-containing motifs (25), the medium chain subunits (µ1, also known as AP47, and µ2, also known as AP50) of clathrin-associated adaptor protein complexes (AP1 and AP2) have been shown to interact with specific tyrosine-containing motifs using yeast two-hybrid systems (26, 27). Phosphorylation of the critical tyrosine residue may not be a requisite event before internalization (27, 28). There are also endocytosis motifs that do not involve tyrosine, such as the di-leucine (29-31) and di-lysine (32) sequences. Depending on the particular molecule, phosphorylation of specific cytoplasmic serine residues membrane-proximal to the di-leucine motifs may (33, 34) or may not (31) be required for efficient endocytosis. Because the medium chains of either of the AP complexes failed to interact with a di-leucine motif studied (26), other subunits of the AP complexes or novel homologs might recognize and interact specifically with this motif. Alternatively, there are diverse molecular endocytic mechanisms by which a variety of signal motifs are recognized and processed (35, 36).

The putative cytoplasmic domain of E-selectin is relatively short (32 amino acid residues). Although E-selectin is related to L- and P- selectin structurally and phylogenetically, they share little homology within this domain. This is in contrast to the relative cross-species conservation of the cytoplasmic domain of E-selectin (Fig. 1A). Accordingly, the fate of E-selectin after surface expression is quite divergent from that of L- and P-selectin. Unlike surface-expressed E-selectin, L-selectin is shed rapidly after leukocyte activation (37). P-selectin, once expressed on the endothelial cell surface, is internalized and subsequently recycled to the cell surface or degraded in lysosomes (15, 38).


Fig. 1. Alignments of known E-selectin (panel A) and transmembrane forms of VCAM-1 (panel B) cytoplasmic domain amino acid sequences among different species. Spaces (dots) are inserted for optimal alignment. Consensus residues are boldfaced. COOH-terminal residues are as indicated.
[View Larger Version of this Image (45K GIF file)]

The cytoplasmic domain of E-selectin contains two tyrosine residues (Tyr582 and Tyr587). One of these, the membrane-proximal residue at position 582 of the mature protein, in the context of its neighboring residues, was predicted to fit a generic structural motif for efficient endocytosis (39). Additionally, the cytoplasmic domain of E-selectin contains a potential endocytosis motif similar to the di-leucine motif at its COOH terminus as well as that similar to the di-lysine motif, described above, in the juxtamembrane region. Surface-expressed E-selectin is phosphorylated at serine residues but not tyrosine residues (14). However, the phosphorylation event was reported to be unrelated to the endocytosis of E-selectin (14). Interestingly, the cytoplasmic domain of human VCAM-1 has a single tyrosine residue that is conserved (Fig. 1B), but, as mentioned above, surface-expressed VCAM-1 is not internalized rapidly. The aim of our study was to define further the endocytosis motif in E-selectin. We show here that neither Tyr582 nor Tyr587 is required for efficient endocytosis of surface E-selectin. Instead, Ser581 and residues membrane-proximal to it are required.


EXPERIMENTAL PROCEDURES

PCR-assisted Site-directed Mutagenesis

Human E-selectin cDNA was a gift from M. Bevilacqua, Amgen, Thousand Oaks, CA (5). The full-length coding region along with 360 base pairs of the 3'-untranslated region of the cDNA was subcloned into the mammalian cell expression vector pDX (kindly provided by K. Kaushansky, University of Washington, Seattle) (40). To generate the various cytoplasmic mutant constructs (Fig. 2), we took advantage of the unique restriction sites, DraIII, located 120 base pairs 5' to the transmembrane domain, and NotI, located at the 3'-end of the subcloned cDNA. For construction of the substitution mutants, sequential PCRs were carried out as described previously (41). In the first PCR, a sense primer corresponding to the DraIII site and an antisense internal mutagenic oligonucleotide were used as the primer pair. In the second PCR, the respective sense internal mutagenic oligonucleotide and the antisense primer corresponding to the NotI site were used as the primer pair. The wild-type (WT) E-selectin construct was used as the template in both of these reactions. In the final PCR, aliquots of melted gel slices containing PCR products from the above reactions were combined as the template; the sense DraIII and the antisense NotI primers were used as the primer pair. The final PCR product was then isolated in and extracted from agarose gel, digested with DraIII and NotI restriction enzymes, and subcloned into the purified WT E-selectin expression vector previously digested with the same enzymes. Applying a similar strategy, we substituted the full-length cytoplasmic tail of human VCAM-1 for that of E-selectin using hybrid mutagenic oligonucleotides having one end complementary to E-selectin transmembrane domain and the other end to VCAM-1 cytoplasmic domain. Human VCAM-1 cDNA (kindly provided by L. Osborn, Biogen, Inc., Cambridge Center, MA) (42) was used as the template in the second PCR reaction described above. For construction of the premature cytoplasmic termination mutants, the NotI site sequence was added immediately downstream from the premature stop codon in the design of the respective antisense mutagenic oligonucleotides. Each of these oligonucleotides, along with the sense DraIII primer as the primer pair and the WT construct as the template, were used to generate a PCR product that was subcloned subsequently into the expression vector as before. Each of the mutant clones generated was sequenced to verify the region spanning from the DraIII site to the NotI site. The deduced cytoplasmic tail amino acid sequences for the various mutants constructs are summarized in Fig. 2.


Fig. 2. Deduced cytoplasmic domain amino acid sequences of E-selectin constructs. Potential internalization motifs found previously in other integral membrane proteins identified in the cytoplasmic domain of WT E-selectin, including di-lysine (KKFV), tyrosine-containing (DGSY, YQKP, KPSY, or YQKPSY), and di-leucine (IL) motifs, are underlined. Boldface denote substitution mutations. Dashes denote internal deletion of amino acid residues at corresponding positions. For positional reference, some of the COOH-terminal residues are numbered.
[View Larger Version of this Image (52K GIF file)]

Transfection

Chinese hamster ovary (CHO) cells were plated onto three 12-well tissue culture plates (Costar, Cambridge, MA) and grown to 70-80% confluence. Each of the wells was inoculated with 500 µl of Opti-MEM (Life Technologies, Inc.) containing LipofectAMINE (Life Technologies, Inc.) at 8 µg/ml and an expression vector construct at 2 µg/ml for 4 h. These were further incubated overnight with the addition of 500 µl/well of regular CHO medium consisting of alpha -minimal essential medium with 10% fetal calf serum and 2 mM L-glutamine. They were then washed and replaced with regular CHO medium. The 125I-CD62E mAb internalization assays were performed 48 h after the initial transfection.

125I Labeling of CD62E mAb

The CD62E mAb, P6E2 (CY1878), was a generous gift from L. Phillips and J. Paulson, Cytel Corporation, San Diego. For each internalization assay, 90 µg of P6E2 was iodinated with 1 mCi of 125I using IODO-BEADS (Pierce Chemical Co.). The reaction was terminated at 12 min of incubation by removing the iodination mixture from the IODO-BEADS. Labeled P6E2 was separated from unincorporated 125I using a size-exclusion desalting column (Presto Column, Pierce). The final eluted volume was adjusted to 18 ml with PBS containing 1 mM MgCl2, 1 mM CaCl2, and 0.1% bovine serum albumin (PBS+).

125I-CD62E mAb Acid Elution/Internalization Assay

We modified the procedure reported previously by von Asmuth et al. (13) to measure the surface kinetics of expressed E-selectin. For a typical experiment, one 12-well CHO cell plate/time point was assayed at 0, 30, and 60 min. Each plate/time point included four groups (in triplicate wells) of CHO cells that had been transiently transfected with the following constructs: WT E-selectin (positive control), Delta Cyto with near total cytoplasmic domain truncation of E-selectin (Fig. 2), vector alone without cDNA insert (background control), and the test construct.

Plates were prechilled on ice and washed twice with ice-cold PBS+. Five hundred µl of prechilled 125I-P6E2/well was added for a 15-min incubation on ice. Each well was then washed three times with 2 ml of cold PBS+ to remove unbound 125I-P6E2. After the last wash, 1 ml/well of regular CHO medium prewarmed to 37 °C was added (at time 0) to the 30- and 60-min plates to initiate active endocytosis, and the plates were placed in 37 °C incubator for the designated duration. At the same time, 1 ml/well of ice-cold regular CHO medium was added to the time 0 plate, which had been kept on ice.

At the appropriate times, the supernatant medium in each well was collected and saved. Each well was then washed once with 1 ml and once with 2 ml of cold PBS+. The washes were saved. The saved supernatant medium and the washes from each respective well were combined and represented the supernatant fraction for that well. Subsequently, each well was incubated for 10 min with 1 ml of cold sodium citrate (0.1 M, pH 3.0) to dissociate surface-bound 125I-P6E2. Additional washes were completed with 1 ml/well sodium citrate followed by 2 ml/well cold PBS+. The acid-eluted and wash aliquots were combined and represented the surface fraction for that well. Finally, the cells in each well were lysed with 1 ml of 1 N NaOH for 30 min at room temperature. Each well was scraped and the content collected. Additional washes with 1 ml/well NaOH followed by 2 ml/well PBS were carried out. The lysis and wash aliquots were combined and represented the internalized fraction for that well. The total radioactivity in each fraction was counted and recorded. Thus, each well represented an independent transfection reaction, yielding three data points (supernatant, surface, and internalized fractions) at a given time point.

Data Analysis for Surface-bound 125I-CD62E mAb Kinetics

For each fraction at a time point, the radioactivity counts from the background control wells (CHO cells transiently transfected with vector alone without cDNA insert) were averaged. The radioactivity count from each of the other wells on the same plate was then adjusted by subtracting the mean background count. The mean background count of the surface fraction at any time point was typically <5% and frequently <1% of the surface fraction counts from the other wells. The adjusted count of each fraction from each well was then expressed as a percentage of the adjusted total count (supernatant, surface, and internalized fractions) of that well. The estimated surface half-lives of the various protein constructs were calculated from rate constants derived from curve fitting using the software KaleidaGraph (Synergy Software, Reading, PA), assuming first-order exponential decay characteristics. Analyses of variance were used to test differences of the surface fractions between relevant constructs at each time points.


RESULTS

The Cytoplasmic Tail of E-selectin Contains an Internalization Signal

In contrast to VCAM-1, E-selectin is internalized efficiently in tumor necrosis factor-activated human umbilical vascular endothelial cells (HUVEC), suggesting that the cytoplasmic tail of E-selectin contains an internalization signal (11, 13). To investigate this possibility further, we first conducted pilot experiments utilizing 125I-labeled human E-selectin mAb P6E2 in the acid elution assay described above, in previously cloned CHO cells stably transfected with the WT human E-selectin cDNA. Consistent with previous studies in HUVEC (13), our results indicated that the majority of the initially surface-bound 125I-P6E2 was internalized by 60 min (Fig. 3). Of note, recycling of surface E-selectin has not been reported, and, compared with that internalized, only a small fraction of surface-expressed E-selectin is shed in HUVEC (13, 16). Furthermore, over the time course studied, the amount of initially surface-bound 125I-P6E2 released into the supernatant medium at 4 °C was negligible (11). Thus, all subsequent experiments were performed on CHO cells transiently transfected with the various cytoplasmic domain constructs and focused on the kinetics of expressed surface E-selectin in the 1st h after labeling with the iodinated mAb.


Fig. 3. 125I-P6E2 acid elution assay. Kinetics of the supernatant, surface, and internalized fractions of E-selectin (see "Experimental Procedures") in CHO cells stably transfected with wild-type (WT) human E-selectin cDNA (n = 4 at each data point) are shown. Note that the majority of the initially surface-bound 125I-P6E2 was internalized or degraded by 60 min. Data were adjusted for background nonspecific activity (see "Experimental Procedures"). Error bars represent 95% confidence intervals.
[View Larger Version of this Image (26K GIF file)]

We first generated a near total cytoplasmic domain truncation construct, Delta Cyto (Fig. 2). At 60 min, the surface fraction of the WT E-selectin decreased substantially to about one-third of the initial value (mean = 36.5%, S.D. = 5.1%, n = 69). With most of the putative cytoplasmic domain truncated except for one amino acid residue, the internalization of Delta Cyto was significantly (p < 0.0001) impaired compared with WT (mean surface fraction at 60 min = 53.0%, S.D. = 4.1%, n = 42, Fig. 4A). Consequently, the surface half-life of Delta Cyto was nearly twice that of the WT (t1/2-WT = 45 min versus t1/2-Delta Cyto = 79 min). The mean internalized fraction of the WT increased to 29.4% (S.D. = 4.3%) at 30 min and plateaued at 60 min (mean = 28.6%, S.D. = 4.1%), whereas that of the Delta Cyto increased to a mean of 18.2% (S.D. = 2.6%) at 30 min and plateaued at 60 min (mean = 17.8%, S.D. = 2.0%) (Fig. 4B). Although reduced compared with WT, a significant fraction of initial Delta Cyto was still internalized. Presumably, the internalization of Delta Cyto occurred as a result of the normally constitutive membrane bulk flow in CHO cells. To define this observation further in CHO cells, the putative cytoplasmic domain of WT E-selectin was replaced with that of human VCAM-1 (Delta VCAM, Fig. 2). Because VCAM-1 internalization is reduced in cytokine-activated HUVEC compared with E-selectin (13), we expected that Delta VCAM would have an internalization kinetics similar to that of Delta Cyto. Indeed, this was the case (Fig. 4). Thus, although elements other than the cytoplasmic domain might also contribute to the endocytosis of E-selectin (43, 44), these results demonstrate that there is a determinant within the cytoplasmic domain which promotes endocytosis of surface-expressed E-selectin in CHO cells.


Fig. 4. Cytoplasmic domain of E-selectin contains an internalization signal. Surface (panel A) and internalized (panel B) fractions of 125I-P6E2 were determined in CHO cells transiently transfected with the wild-type (WT, n = 69), cytoplasmic domain deletion (Delta Cyto, n = 42), or VCAM cytoplasmic domain substitution (Delta VCAM, n = 3) construct. Error bars represent 95% confidence intervals.
[View Larger Version of this Image (15K GIF file)]

Tyrosine Residues Are Not Required for the Efficient Internalization of E-selectin

The tyrosine-based endocytosis motif has been suggested to consist of 4-6 amino acid residues with the critical tyrosine residue located as the 3rd or 6th residue in the signal (45). These include the proposed general motif of YXXØ (46), where Ø represents an amino acid residue with a bulky aliphatic or hydrophobic side chain and the well characterized motif NPXY (17) and others (45). Inspecting the E-selectin cytoplasmic domain reveals several potential tyrosine-based endocytosis motifs: DGSY, YQKP, KPSY, and YQKPSY. Interestingly, the cytoplasmic domain of human VCAM-1 also contains two potential endocytosis motifs, KGSY and YSLV (Fig. 1B) but failed to promote E-selectin endocytosis (Delta VCAM, Fig. 4). Clearly, the mere presence of tyrosine motif-like sequences in the cytoplasmic domain does not necessarily translate to predicted biologic function. To investigate the role of the cytoplasmic region containing the two tyrosine residues in promoting E-selectin endocytosis and to test the previous proposal that Tyr582 was a critical residue that conferred the function of efficient E-selectin internalization (39), we designed several mutant constructs including Delta DGS, in which the cytoplasmic domain was truncated immediately proximal to Tyr582, and Delta LES, in which additional three COOH-terminal residues (DGS) were deleted (Fig. 2). Fig. 5 shows that truncation of both Tyr582 and Tyr587 (Delta DGS) did not significantly alter the internalization of E-selectin. However, deletion of only three additional COOH-terminal residues (DGS) markedly reduced internalization. These results corroborated those obtained using Delta DGSA in which Tyr587 was truncated and Tyr582 was mutated to alanine (Fig. 2). Again, internalization kinetics were similar to WT (Table I). Thus, despite the absence of any tyrosine residue in their cytoplasmic domains, the mutants Delta DGS and Delta DGSA exhibited WT-like surface kinetics. Analyses of the surface kinetics characteristics of additional constructs, Delta DGSY, YDelta F, and YDelta A, further supported the tyrosine-independent nature of the process involved (Table I). Therefore, contrary to prediction, neither the membrane-proximal Tyr582 nor the membrane-distal Tyr587 is required for efficient E-selectin internalization.


Fig. 5. Tyrosine residues are not required for efficient internalization. Surface kinetics of E-selectin-bound 125I-P6E2 were determined in CHO cells transiently transfected with Delta LES (n = 8) versus Delta DGS (n = 3) constructs (see Fig. 2). Note that Tyr582 and Tyr587 are not necessary for promoting internalization of surface E-selectin. The cytoplasmic domain residues of E-selectin proximal to Tyr582 are necessary and sufficient.
[View Larger Version of this Image (25K GIF file)]

Table I. Summary of 125I-P6E2 surface kinetics

+, WT-like; -, Delta Cyto-like; I, intermediate. t1/2 = ln2/rate constant. Rate constants were derived from curve fitting of the surface fraction data (n >=  3 at each time point), assuming first-order exponential decay characteristics.

Construct Characteristics Mean t1/2

min
 Delta VCAM  - 76
 Delta VCAM + SDGS  - 95
 Delta Cyto  - 79
 Delta KKF  - 83
 Delta LES  - 80
 Delta SDG I 57
SDelta A I 54
SYDelta GA I 57
 Delta DGS + 42
 Delta DGSY + 35
 Delta DGSA + 31
DDelta A + 49
 Delta DASY + 42
YDelta F + 47
YDelta A + 49
 Delta PAS + 49
WT + 45

Ser581 Is an Important Residue for Promoting E-selectin Endocytosis

Because the mere addition of three residues, DGS, COOH-terminal to Delta LES, reconstituted efficient internalization of surface E-selectin, we constructed mutants DDelta A, Delta DASY, and SDelta A (Fig. 2) to determine the functional importance of these three residues. Only SDelta A reproducibly showed partial reduction of internalization (Fig. 6A), whereas DDelta A and Delta DASY were similar to WT (Fig. 6B). To confirm this observation, we generated Delta SDG and also utilized a mutant construct SYDelta GA serendipitously discovered by sequencing during the process of screening for SDelta A clones. The surface kinetics of both of these constructs conformed to that of SDelta A (Fig. 6A). Therefore, Ser581 is a critical residue necessary for the efficient endocytosis of surface E-selectin. However, our data derived from Delta VCAM+SDGS (Fig. 2 and Table I) suggested SDGS, or Ser581 per se, is not sufficient for efficient endocytosis of surface E-selectin. Other cytoplasmic residues NH2-terminal to Ser581 likely are necessary for this function. The sequence PASS, however, appeared not to be critical (Delta PASS, Fig. 2 and Table I).


Fig. 6. S581 is an important element for surface E-selectin internalization. Panel A, mutations of Ser581 (SDelta A, n = 9; SYDelta GA, n = 6; Delta SDG, n = 3) reduced E-selectin internalization, whereas (panel B) mutations of Asp579 (DDelta A, n = 6), and Gly580 (Delta DASY, n = 3) did not.
[View Larger Version of this Image (18K GIF file)]


DISCUSSION

The exact mechanism effecting E-selectin endocytosis has not been elucidated. Studies have shown that it is a temperature-sensitive and energy-dependent process that is inhibited by the microtubule-disrupting agents colchicine and vinblastine and the nonspecific kinase inhibitor staurosporine but is not affected by cytochalasin B, protein kinase C, cAMP-dependent protein kinase A, or protein tyrosine kinase inhibitors (11). Once internalized, E-selectin accumulates in the early endosomal compartment of tubulovesicular shape located at the periphery of the cell (11). This process has not been definitively determined to be a clathrin-dependent one. It appears to be a constitutive event, followed by lysosomal degradation, without evidence of recycling (11, 13-15). Interestingly, surface expressed E-selectin is phosphorylated at serine but not tyrosine residues (14).

The membrane-proximal tyrosine residue in E-selectin has been proposed to be part of a structural motif that fits a generic model for efficient endocytosis (39). However, the mere presence of any tyrosine residue, or even a tyrosine motif-like sequence, in the cytoplasmic domain of an integral membrane protein does not necessarily indicate either the utilization of clathrin-dependent endocytotic machinery or the critical involvement of the tyrosine residue in the internalization pathway. VCAM-1, for example, contains a tyrosine in the cytoplasmic domain but is not efficiently internalized (11) (Delta VCAM, Fig. 4). Our results demonstrate that neither the two cytoplasmic tyrosine residues nor the DGSY, KPSY, or YQKPSY sequence is necessary for the efficient endocytosis of E-selectin.

Recently, di-leucine motifs in several integral membrane proteins have been identified as non-tyrosine-based internalization as well as lysosomal targeting signals (29, 30, 33, 47). Although evidence suggests that these motifs probably mediate localization to clathrin-coated pits, definitive proof of the interaction of these motifs with adaptor-associated proteins is lacking (26). Ile-Leu and Leu-Ile motifs are also considered members of the di-leucine motifs that confer similar functions (33). Interestingly, E-selectin also has an Ile-Leu sequence at its COOH terminus. In fact, most of the E-selectin molecules cloned to date have isoleucine and leucine at their COOH termini (Fig. 1). Our results, however, indicate that this motif is not necessary for efficient E-selectin internalization (Delta DGS, Fig. 5).

The roughly 20-amino acid residue juxtamembrane region of the E-selectin cytoplasmic domain is highly conserved among species (Fig. 1). The functional role of this region remains obscure, although it contains a conserved di-lysine sequence similar to a previously presumed ER retention signal, KKXX. When overexpressed, this motif acted as a non-tyrosine-based endocytosis signal (32). The truncation construct Delta LES contains this region but failed to support internalization, having kinetics identical to that of Delta Cyto (Fig. 5). Therefore, the juxtamembrane cytoplasmic segment containing di-lysine residues is alone not sufficient for efficient E-selectin internalization.

The internalization signal for E-selectin appears to be complex but novel. Our results indicate that Ser581 is necessary, but additional residue(s) NH2-terminal to this residue, other than aspartate579 and perhaps glycine580, also contribute(s) to the internalization process. Because surface E-selectin is phosphorylated at serine but not tyrosine residues (14), Ser581 may be phosphorylated and potentially serve as a constitutive endocytosis signal. This is supported by the fact that staurosporine inhibits E-selectin internalization and is an inhibitor of serine kinases (48). Furthermore, the result of applying a neural network-based prediction algorithm, PHDacc, developed at EMBL, Heidelberg, which assess solvent accessibility of amino acid residues (49), to the cytoplasmic sequences of E-selectin suggests that Ser581, among the six serine residues and the two tyrosine residues, is the one most likely exposed.

There are precedents in which cytoplasmic protein-protein-binding interactions are based on the recognition of a phosphoserine and its neighboring sequence motifs (50). Similar associations of serine phosphorylation with non-tyrosine motif-related membrane protein trafficking have also been reported in several studies. For the polymeric immunoglobulin receptor, phosphorylation of a specific cytoplasmic serine residue is required for efficient receptor transcytosis; an alanine mutant is transcytosed only slowly (51). Additionally, an alanine mutation introduced at another cytoplasmic serine residue impairs both internalization and transcytosis (52). Because E-selectin is not known to be transcytosed, it likely utilizes an endocytosis mechanism distinct from that of the polymeric immunoglobulin receptor. Alternatively, the difference might be accounted for by cell-specific mechanisms. For CD4, its down-regulation from the cell surface requires the phosphorylation of three cytoplasmic serine residues (34). However, unlike those in E-selectin, the phosphorylated serine residues in CD4 may be part of the di-leucine endocytosis motif operating in the cytoplasmic domain (33, 53). Finally, specific cytoplasmic serine phosphorylation of some surface receptors has been shown to be associated with ubiquitination of neighboring lysine residues that in turn signal for endocytosis (54, 55).

Recent studies suggested that the cytoplasmic domain of E-selectin was not required for PMN adhesion under static conditions (56), although its association with cytoskeletal proteins upon adhesion did occur (57). Under conditions of flow, PMNs rolled on surface-immobilized soluble E-selectin in a density-dependent manner (4). To confirm our suspicion that the cytoplasmic domain of E-selectin was not essential for PMN rolling under shear, we selected CHO clones stably transfected with WT or Delta Cyto construct and compared the rolling velocities of PMNs under defined shear stresses in a flow chamber. Using methodologies similar to that described (3), we did not observe an impairment in PMN rolling over stable Delta Cyto clones at all shear stresses applied.2

In conclusion, we have identified a critical E-selectin cytoplasmic domain serine residue that is necessary for efficient endocytosis. Other unidentified determinants NH2-terminal to this residue are also required. Contrary to prior prediction, cytoplasmic tyrosine residues appear not involved. Because E-selectin is one of the important molecules in leukocyte recruitment in inflammation, additional studies to identify precise biochemical and structural basis of its internalization may provide insights into the regulation of the inflammatory response.


FOOTNOTES

*   This work was supported by an American Lung Association research training award and American Heart Association clinician-scientist award (to P. I. C.) and United States Public Health Service Grants HL18645 and HL30542 (to J. M. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   To whom correspondence should be addressed: Box 356522, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA 98195-6522. Tel.: 206-731-3170; Fax: 206-685-3062; E-mail: ichuang{at}u.washington.edu.
1   The abbreviations used are: VCAM-1, vascular cell adhesion molecule-1; AP, adaptor protein; PCR, polymerase chain reaction; WT, wild-type; CHO, Chinese hamster ovary; mAb, monoclonal antibody; PBS, phosphate-buffered saline; HUVEC, human umbilical vascular endothelial cells; PMN, polymorphonuclear leukocyte.
2   P. I. Chuang, B. A. Young, R. R. Thiagarajan, C. Cornejo, R. K. Winn, and J. M. Harlan, unpublished observation.

ACKNOWLEDGEMENT

We thank Dr. Kenneth Kaushansky and Dr. Richard Goodman for a critical review of the manuscript and thoughtful input. We also thank Esther Yee and Thomas Eunson for technical assistance.


REFERENCES

  1. von Andrian, U. H., Berger, E. M., Ramezani, L., Chambers, J. D., Ochs, H. D., Harlan, J. M., Paulson, J. C., Etzioni, A., and Arfors, K. E. (1993) J. Clin. Invest. 91, 2893-2897
  2. Olofsson, A. M., Arfors, K. E., Ramezani, L., Wolitzky, B. A., Butcher, E. C., and von Andrian, U. H. (1994) Blood 84, 2749-2758 [Abstract/Free Full Text]
  3. Abbassi, O., Kishimoto, T. K., McIntire, L. V., Anderson, D. C., and Smith, C. W. (1993) J. Clin. Invest. 92, 2719-2730
  4. Lawrence, M. B., and Springer, T. A. (1993) J. Immunol. 151, 6338-6346 [Abstract]
  5. Bevilacqua, M. P., Stengelin, S., Gimbrone, M. A. J., and Seed, B. (1989) Science 243, 1160-1165 [Abstract/Free Full Text]
  6. Issekutz, A. C., and Lopes, N. (1993) Immunology 79, 600-607 [Medline] [Order article via Infotrieve]
  7. Norris, P., Poston, R. N., Thomas, D. S., Thornhill, M., Hawk, J., and Haskard, D. O. (1991) J. Invest. Dermatol. 96, 763-770 [CrossRef][Medline] [Order article via Infotrieve]
  8. Leeuwenberg, J. F., von Asmuth, E. J., Jeunhomme, T. M., and Buurman, W. A. (1990) J. Immunol. 145, 2110-2114 [Abstract]
  9. Pigott, R., Dillon, L. P., Hemingway, I. H., and Gearing, A. J. (1992) Biochem. Biophys. Res. Commun. 187, 584-589 [CrossRef][Medline] [Order article via Infotrieve]
  10. Cartwright, J. E., Whitley, G. S., and Johnstone, A. P. (1995) Exp. Cell Res. 217, 329-335 [CrossRef][Medline] [Order article via Infotrieve]
  11. Kuijpers, T. W., Raleigh, M., Kavanagh, T., Janssen, H., Calafat, J., Roos, D., and Harlan, J. M. (1994) J. Immunol. 152, 5060-5069 [Abstract]
  12. Leca, G., Mansur, S. E., and Bensussan, A. (1995) J. Immunol. 154, 1069-1077 [Abstract]
  13. von Asmuth, E. J., Smeets, E. F., Ginsel, L. A., Onderwater, J. J., Leeuwenberg, J. F., and Buurman, W. A. (1992) Eur. J. Immunol. 22, 2519-2526 [Medline] [Order article via Infotrieve]
  14. Smeets, E. F., de Vries, T., Leeuwenberg, J. F., van den Eijnden, D. H., Buurman, W. A., and Neefjes, J. J. (1993) Eur. J. Immunol. 23, 147-151 [Medline] [Order article via Infotrieve]
  15. Subramaniam, M., Koedam, J. A., and Wagner, D. D. (1993) Mol. Biol. Cell 4, 791-801 [Abstract]
  16. Leeuwenberg, J. F., Smeets, E. F., Neefjes, J. J., Shaffer, M. A., Cinek, T., Jeunhomme, T. M., Ahern, T. J., and Buurman, W. A. (1992) Immunology 77, 543-549 [Medline] [Order article via Infotrieve]
  17. Chen, W.-J., Goldstein, J. L., and Brown, M. S. (1990) J. Biol. Chem. 265, 3116-3123 [Abstract/Free Full Text]
  18. Davis, C. G., Lehrman, M. A., Russell, D. W., Anderson, R. G., Brown, M. S., and Goldstein, J. L. (1986) Cell 45, 15-24 [CrossRef][Medline] [Order article via Infotrieve]
  19. Eberle, W., Sander, C., Klaus, W., Schmidt, B., von Figura, K., and Peters, C. (1991) Cell 67, 1203-1209 [CrossRef][Medline] [Order article via Infotrieve]
  20. Bansal, A., and Gierasch, L. M. (1991) Cell 67, 1195-1201 [CrossRef][Medline] [Order article via Infotrieve]
  21. Collawn, J. F., Stangel, M., Kuhn, L. A., Esekogwu, V., Jing, S. Q., Trowbridge, I. S., and Tainer, J. A. (1990) Cell 63, 1061-1072 [CrossRef][Medline] [Order article via Infotrieve]
  22. Trowbridge, I. S., and Collawn, J. F. (1992) J. Inorg. Biochem. 47, 209-217 [CrossRef][Medline] [Order article via Infotrieve]
  23. Sorkin, A., and Carpenter, G. (1993) Science 261, 612-615 [Abstract/Free Full Text]
  24. Sosa, M. A., Schmidt, B., von Figura, K., and Hille-Rehfeld, A. (1993) J. Biol. Chem. 268, 12537-12543 [Abstract/Free Full Text]
  25. Wilde, A., Dempsey, C., and Banting, G. (1994) J. Biol. Chem. 269, 7131-7136 [Abstract/Free Full Text]
  26. Ohno, H., Stewart, J., Fournier, M. C., Bosshart, H., Rhee, I., Miyatake, S., Saito, T., Gallusser, A., Kirchhausen, T., and Bonifacino, J. S. (1995) Science 269, 1872-1875 [Abstract/Free Full Text]
  27. Ohno, H., Fournier, M.-C., Poy, G., and Bonifacino, J. S. (1996) J. Biol. Chem. 271, 29009-29015 [Abstract/Free Full Text]
  28. Myles, G. M., Brandt, C. S., Carlberg, K., and Rohrschneider, L. R. (1994) Mol. Cell. Biol. 14, 4843-4854 [Abstract/Free Full Text]
  29. Letourneur, F., and Klausner, R. D. (1992) Cell 69, 1143-1157 [CrossRef][Medline] [Order article via Infotrieve]
  30. Pond, L., Kuhn, L. A., Teyton, L., Schutze, M. P., Tainer, J. A., Jackson, M. R., and Peterson, P. A. (1995) J. Biol. Chem. 270, 19989-19997 [Abstract/Free Full Text]
  31. Ogata, S., and Fukuda, M. (1994) J. Biol. Chem. 269, 5210-5217 [Abstract/Free Full Text]
  32. Itin, C., Kappeler, F., Linstedt, A. D., and Hauri, H. P. (1995) EMBO J. 14, 2250-2256 [Medline] [Order article via Infotrieve]
  33. Dietrich, J., Hou, X., Wegener, A. M., and Geisler, C. (1994) EMBO J. 13, 2156-2166 [Medline] [Order article via Infotrieve]
  34. Shin, J., Doyle, C., Yang, Z., Kappes, D., and Strominger, J. L. (1990) EMBO J. 9, 425-434 [Medline] [Order article via Infotrieve]
  35. Marks, M. S., Woodruff, L., Ohno, H., and Bonifacino, J. S. (1996) J. Cell Biol. 135, 341-354 [Abstract/Free Full Text]
  36. Lamaze, C., and Schmid, S. L. (1995) Curr. Opin. Cell Biol. 7, 573-580 [CrossRef][Medline] [Order article via Infotrieve]
  37. Spertini, O., Freedman, A. S., Belvin, M. P., Penta, A. C., Griffin, J. D., and Tedder, T. F. (1991) Leukemia 5, 300-308 [Medline] [Order article via Infotrieve]
  38. Green, S. A., Setiadi, H., McEver, R. P., and Kelly, R. B. (1994) J. Cell Biol. 124, 435-448 [Abstract/Free Full Text]
  39. Ktistakis, N. T., Thomas, D., and Roth, M. G. (1990) J. Cell Biol. 111, 1393-1407 [Abstract/Free Full Text]
  40. Kane, W. H., Devore-Carter, D., and Ortel, T. L. (1990) Biochemistry 29, 6762-6768 [CrossRef][Medline] [Order article via Infotrieve]
  41. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59 [CrossRef][Medline] [Order article via Infotrieve]
  42. Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi, R.-G., and Lobb, R. (1989) Cell 59, 1203-1211 [CrossRef][Medline] [Order article via Infotrieve]
  43. Setiadi, H., Disdier, M., Green, S. A., Canfield, W. M., and McEver, R. P. (1995) J. Biol. Chem. 270, 26818-26826 [Abstract/Free Full Text]
  44. Verrey, F., Gilbert, T., Mellow, T., Proulx, G., and Drickamer, K. (1990) Cell Regul. 1, 471-486 [Medline] [Order article via Infotrieve]
  45. Naim, H. Y., and Roth, M. G. (1994) J. Biol. Chem. 269, 3928-3933 [Abstract/Free Full Text]
  46. Thomas, D. C., and Roth, M. G. (1994) J. Biol. Chem. 269, 15732-15739 [Abstract/Free Full Text]
  47. Corvera, S., Chawla, A., Chakrabarti, R., Joly, M., Buxton, J., and Czech, M. P. (1994) J. Cell Biol. 126, 979-989 [Abstract/Free Full Text]
  48. Meggio, F., Donella, D.-A., Ruzzene, M., Brunati, A. M., Cesaro, L., Guerra, B., Meyer, T., Mett, H., Fabbro, D., Furet, P., Dobrowolska, G., and Pinna, L. A. (1995) Eur. J. Biochem. 234, 317-322 [Medline] [Order article via Infotrieve]
  49. Rost, B., and Sander, C. (1995) Proteins 23, 295-300 [CrossRef][Medline] [Order article via Infotrieve]
  50. Muslin, A. J., Tanner, J. W., Allen, P. M., and Shaw, A. S. (1996) Cell 84, 889-897 [CrossRef][Medline] [Order article via Infotrieve]
  51. Casanova, J. E., Breitfeld, P. P., Ross, S. A., and Mostov, K. E. (1990) Science 248, 742-745 [Abstract/Free Full Text]
  52. Okamoto, C. T., Song, W., Bomsel, M., and Mostov, K. E. (1994) J. Biol. Chem. 269, 15676-15682 [Abstract/Free Full Text]
  53. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E., and Trono, D. (1994) Cell 76, 853-864 [CrossRef][Medline] [Order article via Infotrieve]
  54. Hicke, L., and Riezman, H. (1996) Cell 84, 277-287 [CrossRef][Medline] [Order article via Infotrieve]
  55. Kolling, R., and Hollenberg, C. P. (1994) EMBO J. 13, 3261-3271 [Medline] [Order article via Infotrieve]
  56. Kansas, G. S., and Pavalko, F. M. (1996) J. Immunol. 157, 321-325 [Abstract]
  57. Yoshida, M., Westlin, W. F., Wang, N., Ingber, D. E., Rosenzweig, A., Resnick, N., and Gimbrone, M. A., Jr. (1996) J. Cell Biol. 133, 445-455 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. Setiadi and R. P. McEver
Clustering endothelial E-selectin in clathrin-coated pits and lipid rafts enhances leukocyte adhesion under flow
Blood, February 15, 2008; 111(4): 1989 - 1998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Bhaskar, D. A. Law, E. Ibsen, D. Breinberg, K. M. Cass, R. B. DuBridge, F. Evangelista, S. M. Henshall, P. Hevezi, J. C. Miller, et al.
E-Selectin Up-Regulation Allows for Targeted Drug Delivery in Prostate Cancer
Cancer Res., October 1, 2003; 63(19): 6387 - 6394.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. M. Burdick, J. M. McCaffery, Y. S. Kim, B. S. Bochner, and K. Konstantopoulos
Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow
Am J Physiol Cell Physiol, April 1, 2003; 284(4): C977 - C987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. S. Kluger, S. L. Shiao, A. L. M. Bothwell, and J. S. Pober
Cutting Edge: Internalization of Transduced E-Selectin by Cultured Human Endothelial Cells: Comparison of Dermal Microvascular and Umbilical Vein Cells and Identification of a Phosphoserine-Type Di-leucine Motif
J. Immunol., March 1, 2002; 168(5): 2091 - 2095.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
H. Setiadi, G. Sedgewick, S. L. Erlandsen, and R. P. McEver
Interactions of the Cytoplasmic Domain of P-Selectin with Clathrin-coated Pits Enhance Leukocyte Adhesion under Flow
J. Cell Biol., August 10, 1998; 142(3): 859 - 871.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Govers, P. van Kerkhof, A. L. Schwartz, and G. J. Strous
Di-leucine-mediated Internalization of Ligand by a Truncated Growth Hormone Receptor Is Independent of the Ubiquitin Conjugation System
J. Biol. Chem., June 26, 1998; 273(26): 16426 - 16433.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chuang, P. I.
Right arrow Articles by Harlan, J. M.